Skip to content
2000
Volume 28, Issue 15
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

COVID-19, a type of infection that emerged in Wuhan, has become a pandemic affecting people worldwide and is rapidly spreading and evolving. Day by day, the confirmed cases and deaths are increasing many folds. SARS-CoV-2 is a novel virus; therefore, limited data are available to curb the disease. Epidemiological approaches, such as isolation, quarantine, social distancing, lockdown, and curfew, are being employed to halt the spread of the disease. Individual and joint efforts all over the world are producing a wealth of data and information which are expected to produce therapeutic strategies against COVID-19. Current research focuses on the utilization of antiviral drugs, repurposing strategies, vaccine development, as well as basic to advanced research about the organism and the infection. The review focuses on its life cycle, targets, and possible therapeutic strategies, which can lead to further research and development of COVID-19 therapy.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/0929867327666200702151018
2021-05-01
2025-05-06
Loading full text...

Full text loading...

/content/journals/cmc/10.2174/0929867327666200702151018
Loading

  • Article Type:
    Review Article
Keyword(s): ACE2; Antiviral drugs; coronavirus; COVID-19; Drug repurposing; MERS-CoV; SARS-CoV; SARS-CoV-2; Vaccines
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test